Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
14.46
0.04 (0.28%)
At close: Aug 15, 2025, 3:59 PM
14.08
-2.66%
After-hours: Aug 15, 2025, 05:42 PM EDT
Keros Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 690.22M | 720.54M | 559.93M | 530.68M | 405.86M | 442.44M | 331.15M | 287.89M | 322.03M | 351.43M | 279.05M | 239.43M | 215.62M | 228.59M | 230.04M | 221.35M | 237.11M | 255.2M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 1.45M | 1.45M | 1.45M | 1.45M | 1.21M | 1.21M | 1.21M | 1.21M | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 115K | 115K |
Other Long-Term Assets | n/a | 463K | 2.06M | 1.59M | 2.15M | 2.05M | 2.05M | 1.57M | 1.57M | 1.59M | 2.12M | 3.22M | 667K | 275K | 82K | n/a | n/a | n/a |
Receivables | 15.82M | 19.37M | 4.46M | 1.92M | 1.34M | 1.78M | 1.09M | 898K | 964K | 1.15M | 841K | 146K | 146K | 167K | 18M | 169K | 245K | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | 14.05M | 15.32M | 10.94M | 9.13M | -841K | 5.56M | 6.12M | 2.22M | 3.06M | 4.24M | 3.77M | n/a |
Other Current Assets | 26.78M | 2.94M | 1.48M | 1.39M | 582K | 616K | 1M | 319K | 376K | 515K | 180K | 745K | 466K | 251K | 340K | 313K | 290K | 265K |
Total Current Assets | 732.81M | 759.51M | 588.89M | 552.05M | 432.71M | 463.13M | 347.29M | 304.44M | 334.31M | 362.22M | 285.77M | 245.88M | 222.36M | 231.22M | 251.44M | 226.07M | 241.42M | 255.98M |
Property-Plant & Equipment | 22.91M | 23.14M | 23.49M | 24.19M | 18.94M | 19.43M | 19.47M | 19.03M | 19.1M | 19.3M | 17.57M | 2.13M | 2.31M | 2.32M | 2.4M | 2.56M | 1.93M | 1.63M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 24.36M | 25.05M | 26.99M | 27.23M | 22.31M | 22.69M | 22.73M | 21.81M | 22M | 22.21M | 21.01M | 6.67M | 4.3M | 3.92M | 3.81M | 3.89M | 2.04M | 1.75M |
Total Assets | 757.16M | 784.56M | 615.89M | 579.27M | 455.02M | 485.82M | 370.02M | 326.25M | 356.31M | 384.44M | 306.78M | 252.55M | 226.66M | 235.14M | 255.25M | 229.96M | 243.46M | 257.73M |
Account Payables | 5.27M | 6.64M | 4.6M | 4.98M | 6.54M | 4.99M | 5.45M | 3.87M | 4.15M | 4.68M | 3.34M | 2.65M | 7.66M | 3.06M | 3.65M | 2.81M | 1.37M | 3.01M |
Deferred Revenue | 925K | 3.31M | n/a | n/a | n/a | -1.05M | 17.25M | 11.82M | n/a | n/a | n/a | n/a | n/a | n/a | 7.13M | 7.16M | 5.04M | 5.3M |
Short-Term Debt | 2.23M | n/a | n/a | n/a | 1.1M | 1.05M | n/a | 611K | n/a | n/a | n/a | 455K | 670K | 884K | n/a | 843K | 449K | 436K |
Other Current Liabilities | 26.29M | 5.82M | 416K | 8.38M | 7.21M | 7.7M | 10.38M | 5.9M | 4.49M | 7.96M | 7.89M | 4.05M | 3.63M | 5.5M | 4.86M | 4.67M | 3.99M | 4.29M |
Total Current Liabilities | 34.71M | 39.38M | 27.45M | 29.01M | 21.25M | 18.72M | 24.37M | 16.7M | 16.09M | 15.46M | 16.55M | 11.53M | 15.45M | 11.65M | 11.85M | 11.02M | 7.53M | 8.95M |
Long-Term Debt | 15.72M | n/a | n/a | n/a | 12.86M | 13.15M | n/a | 13.7M | 13.95M | 13.99M | n/a | n/a | n/a | n/a | n/a | 453K | 242K | 361K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | -12.86M | -13.15M | n/a | -13.7M | -13.95M | -13.99M | n/a | n/a | n/a | n/a | n/a | -437K | -210K | -314K |
Total Long-Term Liabilities | 15.72M | 16.31M | 16.88M | 17.43M | 12.86M | 13.15M | 13.44M | 13.7M | 13.95M | 13.99M | 12.81M | 455K | 670K | 3.95M | 231K | 469K | 274K | 408K |
Total Liabilities | 50.43M | 55.69M | 44.33M | 46.44M | 34.11M | 31.87M | 37.81M | 30.41M | 30.05M | 29.45M | 29.36M | 11.53M | 15.45M | 11.65M | 12.08M | 11.48M | 7.8M | 9.36M |
Total Debt | 17.95M | 18.41M | 18.86M | 19.29M | 13.96M | 14.2M | 14.44M | 14.31M | 13.95M | 13.99M | 13.27M | 455K | 670K | 884K | 1.09M | 1.3M | 691K | 797K |
Common Stock | 4K | 4K | 4K | 4K | 3K | 3K | 3K | 3K | 3K | 3K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K |
Retained Earnings | -451.02M | -420.33M | -568.78M | -522.75M | -469.8M | -424.54M | -381.43M | -341.18M | -301.74M | -264.24M | -228.43M | -198.72M | -175.21M | -147.94M | -123.75M | -116.81M | -96.52M | -80.9M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | -0.00 | n/a | -0.00 | -0.00 | 0.00 | -0.00 | n/a | -0.00 | n/a | -0.00 | -0.00 |
Shareholders Equity | 706.73M | 728.87M | 571.55M | 532.84M | 420.92M | 453.95M | 332.21M | 295.84M | 326.26M | 354.98M | 277.42M | 241.03M | 211.21M | 223.49M | 243.17M | 218.48M | 235.66M | 248.37M |
Total Investments | 1.45M | 1.45M | 1.45M | 1.45M | 1.21M | 1.21M | 1.21M | 1.21M | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 115K | 115K |